We will upload information about the latest recipients to have been awarded HRC funding for all of our funding opportunities as this information becomes officially available.

The information provided is for ‘year to date’ funding.

Previous Recipient List

  • 2009 Funding Round
    Dr Elspeth Gold
    University of Otago, Dunedin
    Role of activin C in prostate disease
    $953,695
    36 months
  • 2009 Funding Round
    Ms Delvina Gorton
    The University of Auckland
    The effects of a school breakfast programme on school achievement and nutrition
    $810,753
    24 months
  • 2013 Funding Round
    Professor Merryn Gott
    The University of Auckland
    Pakeketanga: Living and dying in advanced age
    $1,191,255
    36 months
  • 2009 Funding Round
    Associate Professor Cameron Grant
    The University of Auckland
    Randomised placebo controlled study of vitamin D during pregnancy and infancy
    $958,341
    30 months
  • 2016 Funding Round - Project
    Associate Professor Cameron Grant
    University of Auckland
    Effect of early childhood ear infections on language, cognition and behavior
    $1,191,663
    36 months
  • 2009 Funding Round
    Associate Professor David Grattan
    University of Otago, Dunedin
    Mechanisms of hyperprolactinemia-induced infertility
    $949,105
    36 months
  • 2013 Funding Round
    Professor David Grattan
    University of Otago, Dunedin
    Role of kisspeptin in hyperprolactinemia-induced infertility
    $1,164,184
    36 months
  • 2016 Funding Round - Project
    Professor David Grattan
    University of Otago, Dunedin
    Role of hypothalamic beta-catenin in body weight regulation
    $1,195,099
    36 months
  • 2013 Funding Round
    Dr Katie Groom
    The University of Auckland
    STRIDER (NZAus): RCT of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction (IUGR)
    $1,147,306
    36 months
  • 2011 Funding Round
    Associate Professor Parry Guilford
    University of Otago, Dunedin
    Synthetic lethal Targeting of the Tumour Suppressor Gene CDH1 in Common Cancers
    $1,080,001
    36 months
  • 2011 Funding Round
    Associate Professor Parry Guilford
    University of Otago, Dunedin
    Single Cell RNA Profiling for the Early Detection of Urological Cancers
    $820,303
    36 months
  • 2015 Funding Round - Project
    Professor Parry Guilford
    University of Otago, Dunedin
    The chemoprevention and treatment of diffuse gastric cancer
    $1,189,286
    36 months
  • 2014 Funding Round – Project
    Professor Alistair Gunn
    The University of Auckland
    Protecting brain development after clinically silent infection before birth
    $1,151,828
    36 months
  • Project
    Professor Leigh Hale
    University of Otago, Dunedin
    Community exercise for long-term management of diabetes and multimorbidity
    $1,181,772
    36 months
  • Projects
    Professor Leigh Hale
    University of Otago, Dunedin
    Co-creating a digital self-help intervention for people with persistent pain
    $1,198,177
    36 months
  • Project
    Dr Christopher Hall
    University of Auckland
    Targeting crystal-driven macrophage activation to suppress gouty inflammation
    $1,185,170
    36 months
  • 2008 Funding Round
    Dr Mark Hampton
    University of Otago, Christchurch
    Peroxiredoxins in antioxidant defence and cell signalling
    $1,520,054
    36 months
  • 2008 Funding Round
    Dr Robert Hancox
    University of Otago, Dunedin
    The Dunedin Next Generation Studies
    $1,850,398
    60 months
  • 2016 Funding Round - Project
    Associate Professor Bob Hancox
    University of Otago, Dunedin
    The next generation studies
    $1,195,331
    36 months
  • 2010 Funding Round
    Professor Jane Harding
    The University of Auckland
    Neonatal Hypoglycaemia: How do we know how low is too low?
    $1,061,608
    36 months